Matches in Wikidata for { <http://www.wikidata.org/entity/Q73762841> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q73762841 description "artículu científicu espublizáu en setiembre de 1997" @default.
- Q73762841 description "im September 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73762841 description "scientific article published on 01 September 1997" @default.
- Q73762841 description "wetenschappelijk artikel" @default.
- Q73762841 description "наукова стаття, опублікована у вересні 1997" @default.
- Q73762841 name "Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome" @default.
- Q73762841 name "Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome" @default.
- Q73762841 type Item @default.
- Q73762841 label "Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome" @default.
- Q73762841 label "Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome" @default.
- Q73762841 prefLabel "Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome" @default.
- Q73762841 prefLabel "Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome" @default.
- Q73762841 P1433 Q73762841-03570A70-1214-4EFB-BDE7-ABDB428A9C05 @default.
- Q73762841 P1476 Q73762841-19E06D34-0C45-4C5E-B4D2-FFBEA41E47C5 @default.
- Q73762841 P2093 Q73762841-080E7036-63CF-4CDB-B10B-AD9A2347501D @default.
- Q73762841 P2093 Q73762841-BE3DE3A2-B039-4CB5-8855-A4FA1EE10D83 @default.
- Q73762841 P304 Q73762841-BEB64CC2-5E76-437F-80B0-F10ECC5FB06E @default.
- Q73762841 P31 Q73762841-1FEB76C2-0CE5-44BD-AA17-45E750871BAC @default.
- Q73762841 P356 Q73762841-02486D17-8088-43B4-8823-27FD4B0822C3 @default.
- Q73762841 P407 Q73762841-7287F2B6-482F-4687-8B70-B04C6DAF8AA3 @default.
- Q73762841 P433 Q73762841-BC05EF4E-0B8D-43FF-80B4-6AFD60916359 @default.
- Q73762841 P478 Q73762841-A0E6FDD6-BAE6-4BC1-A437-16995C7B7F55 @default.
- Q73762841 P577 Q73762841-74E81F8F-B464-4AE8-9D53-0227DA3DA770 @default.
- Q73762841 P698 Q73762841-80442A67-F187-4514-A329-5A271C708679 @default.
- Q73762841 P356 01.CIR.96.6.2038 @default.
- Q73762841 P698 9323097 @default.
- Q73762841 P1433 Q578091 @default.
- Q73762841 P1476 "Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome" @default.
- Q73762841 P2093 "Antzelevitch C" @default.
- Q73762841 P2093 "Shimizu W" @default.
- Q73762841 P304 "2038-2047" @default.
- Q73762841 P31 Q13442814 @default.
- Q73762841 P356 "10.1161/01.CIR.96.6.2038" @default.
- Q73762841 P407 Q1860 @default.
- Q73762841 P433 "6" @default.
- Q73762841 P478 "96" @default.
- Q73762841 P577 "1997-09-01T00:00:00Z" @default.
- Q73762841 P698 "9323097" @default.